Marla C. Dubinsky, MD

Mount Sinai Kravis Children’s Hospital

Poster(s):

• P3598 - Corticosteroid-Sparing Effect of Upadacitinib in Patients With Moderately-to-Severely Active Crohn’s Disease
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT

• P3599 - Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients with Ulcerative Colitis, Crohn’s Disease, and Relapsing Multiple Sclerosis
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT

• P3600 - PRA023 Improved Bowel Urgency, Nocturnal Bowel Movement, Nocturnal Waking, and Abdominal Pain in a Phase 2 Trial of Patients with Moderately to Severely Active Ulcerative Colitis
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT

• P3601 - Impact of Tofacitinib Maintenance Therapy on Key Ulcerative Colitis Patient-Reported Outcomes of Fatigue, Urgency, Abdominal Pain, and Sexual Dysfunction Using IBDQ and SF-36 Individual Items as Proxies
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT

• P3602 - Bowel Urgency and Abdominal Pain in Patients with Moderately to Severely Active Ulcerative Colitis in the Etrasimod ELEVATE UC Clinical Program: A Post Hoc Analysis
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT

• P3603 - Efficacy and Safety of Etrasimod in Patients With Moderate to Severe Isolated Proctitis Relative to Those With More Extensive Colitis: Results From the Phase 3 ELEVATE UC 52 and ELEVATE UC 12 Trials
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT

• P3604 - Time to Relapse During Upadacitinib Maintenance Therapy in Patients with Ulcerative Colitis Who Had a Clinical Response to Induction Therapy
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT

• P3605 - Communicating Needs and Features of IBD Experiences (CONFIDE) Survey: Prevalence and Experiences of Bowel Urgency–Comparison Between Male and Female Patients With Moderate-to-Severe Ulcerative Colitis
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT

• P3606 - Assessing Bowel Urgency in Clinical Practice: Results From a Healthcare Professional Survey
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT

• P3607 - The Nucleotide-Binding Oligomerization Domain, Leucine Rich Repeat Containing X1 Agonist NX-13 Demonstrates Rapid Symptomatic and Biomarkers Improvement in Ulcerative Colitis: Results in a Phase 1b Study
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT